Latest Schedule 13G passive stakes

Viking Global Investors filed an amended Schedule 13G to reflect the retirement of David C. Ott from its reporting group.

Viking Global Investors filed an amended Schedule 13G to reflect the retirement of David C. Ott as a reporting person.

Viking Global Investors filed an amended Schedule 13G to reflect the removal of David C. Ott as a reporting person.

Viking Global Investors filed an amendment to its Schedule 13G, reporting a 7.1% beneficial ownership stake in Fortive Corp following the retirement of David C. Ott.

Viking Global Investors LP filed an amendment to its Schedule 13G, reporting a 9.99% beneficial ownership stake in Rallybio Corporation.

Viking Global Investors and its affiliates have reported a 0% beneficial ownership stake in Chewy, Inc. as of March 31, 2026.

Viking Global Investors LP and associated entities reported a 7.8% beneficial ownership stake in Oric Pharmaceuticals, Inc. as of March 31, 2026.

Viking Global Investors LP and associated entities filed an amendment to their Schedule 13G, reporting a 4.5% beneficial ownership stake in Veradermics, Inc. following the retirement of David C. Ott.

Viking Global Investors filed an amended Schedule 13G to reflect the retirement of David C. Ott from its reporting group regarding Ginkgo Bioworks.

Viking Global Investors LP filed an amendment to its Schedule 13G, reporting a 5.6% beneficial ownership stake in Pharvaris N.V. following the retirement of David C. Ott.

Viking Global Investors filed an amendment to its Schedule 13G regarding PepGen Inc. to reflect the removal of David C. Ott as a reporting person following his retirement.

Viking Global Investors filed an amended Schedule 13G to reflect the retirement of David C. Ott from its reporting group.

Viking Global Investors LP filed an amendment to its Schedule 13G, reporting a 16.2% beneficial ownership stake in TIC Solutions, Inc. following the retirement of David C. Ott.

Viking Global Investors filed an amended Schedule 13G to reflect the retirement of David C. Ott from its reporting group.

Nut Tree Capital Management, LP has reported an 8.3% beneficial ownership stake in Trinseo PLC as of March 31, 2026.

Two Seas Capital LP and affiliates have reported a 9.99% beneficial ownership stake in PAVmed Inc. common stock.

LexinFintech Holdings Ltd. founder Jay Wenjie Xiao reports beneficial ownership of 25.8% of the company's ordinary shares.

Orion Resource Partners (USA) LP reports a 2.6% beneficial ownership stake in i-80 Gold Corp. as of March 31, 2026.

Mark N. Tompkins has filed an exit statement for Aeluma, Inc. after his beneficial ownership dropped below the 5% reporting threshold.

Anchorage Capital Group and affiliates have reported an 8.3% beneficial ownership stake in EquipmentShare.com Inc.

Morgan Stanley and affiliated entities have filed a Schedule 13G reporting a 6.2% beneficial ownership stake in Presidio Production Company.

Morgan Stanley and affiliated entities have filed a Schedule 13G reporting a 6.2% beneficial ownership stake in Presidio Production Company.

Two Seas Capital LP has filed an amended Schedule 13G reporting an 8.2% beneficial ownership stake in Veradigm Inc.

Two Seas Capital LP and Sina Toussi have reported a 9.4% beneficial ownership stake in Arbutus Biopharma Corporation.

Manulife Financial Corporation and its subsidiaries have filed a Schedule 13G reporting a 5.26% beneficial ownership stake in Xperi Inc.

Manulife Financial Corporation and its subsidiaries have filed a Schedule 13G reporting a 5.26% beneficial ownership stake in Xperi Inc.

Polar Capital Holdings Plc has filed a Schedule 13G reporting an 8.46% beneficial ownership stake in Enliven Therapeutics, Inc.

Stonepine Capital Management, LLC and associated entities have filed a Schedule 13G reporting a 3.7% beneficial ownership stake in Tenax Therapeutics, Inc.

Manulife Investment Management (US) LLC has reported a 7.47% beneficial ownership stake in SB Financial Group, Inc. common stock.

Manulife Investment Management (US) LLC has reported a 7.47% beneficial ownership stake in SB Financial Group, Inc. common stock.